首页 | 本学科首页   官方微博 | 高级检索  
检索        


Liver Transplantation for Hepatocellular Carcinoma: Results of Down‐Staging in Patients Initially Outside the Milan Selection Criteria
Authors:M Ravaioli  G L Grazi  F Piscaglia  F Trevisani  M Cescon  G Ercolani  M Vivarelli  R Golfieri  A D'Errico Grigioni  I Panzini  C Morelli  M Bernardi  L Bolondi  A D Pinna
Institution:1. Department of Liver and Multi‐organ Transplantation;2. Department of Gastroenterology and Internal Medicine;3. Department of Radiology;4. Department of Onco‐hematology, Pathology Division of the ‘F. Addarii’ Institute, Sant' Orsola‐Malpighi Hospital, University of Bologna, Bologna, Italy;5. Department of Research and Innovation, Hospital of Rimini, Rimini, Italy
Abstract:Conventional criteria for liver transplantation for patients with hepatocellular carcinoma are single HCC ≤ 5 cm or less than or equal to three HCCs ≤ 3 cm. We prospectively evaluated the possibility of slightly extending these criteria in a down‐staging protocol, which included patients initially outside conventional criteria: single HCC 5–6 cm or two HCCs ≤ 5 cm or less than six HCCs ≤ 4 cm and sum diameter ≤ 12 cm, but within Milan criteria in the active tumors after the down‐staging procedures. The outcome of patients down‐staged was compared to that of Milan criteria after liver transplantation and since the first evaluation according to an intention‐to‐treat principle. From 2003 to 2006, 177 patients with HCC were considered for transplantation: the transplantation rate was comparable between the Milan and down‐staging groups: 88/129 cases (68%) versus 32/48 cases (67%), respectively. At a median follow‐up of 2.5 years after transplantation, the 1 and 3 years' disease‐free survival rates were comparable: 80% and 71% in the Milan group versus 78% and 71% in the down‐staging. The actuarial intention‐to‐treat survival was 27/48 patients (56.3%) in the down‐staging and 81/129 cases (62.8%) in the Milan group, p = n.s. The proposed down‐staging criteria provide a comparable outcome to the conventional criteria.
Keywords:Allocation  hepatocellular carcinoma  liver transplantation  MELD score  patient survival  selection criteria  tumor recurrence
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号